Varex Imaging Files Definitive Proxy Statement

Ticker: VREX · Form: DEF 14A · Filed: Dec 30, 2024 · CIK: 1681622

Sentiment: neutral

Topics: proxy-statement, governance, sec-filing

Related Tickers: VREX

TL;DR

Varex Imaging (VREX) filed its proxy statement. Shareholders vote soon.

AI Summary

Varex Imaging Corp. filed its definitive proxy statement (DEF 14A) on December 30, 2024, for its fiscal year ending September 27, 2025. The filing, related to the 1934 Securities Exchange Act, outlines information for shareholders regarding upcoming meetings and voting matters. The company is headquartered in Salt Lake City, UT, with a business phone number of 801-972-5000.

Why It Matters

This filing is crucial for shareholders as it details how they can vote on company matters, elect directors, and understand executive compensation, directly impacting corporate governance.

Risk Assessment

Risk Level: low — A DEF 14A filing is a routine disclosure and does not inherently present new risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of a DEF 14A filing?

A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxy votes from shareholders for annual or special meetings, detailing matters to be voted upon such as director elections and executive compensation.

When was this specific Varex Imaging DEF 14A filed?

This specific DEF 14A filing for Varex Imaging Corp. was filed on December 30, 2024.

What is Varex Imaging Corp.'s fiscal year end?

Varex Imaging Corp.'s fiscal year ends on September 27.

What is the company's primary business address?

Varex Imaging Corp.'s business address is 1678 S. Pioneer Road, Salt Lake City, UT 84104.

Under which SEC Act is this filing made?

This filing is made pursuant to Section 14(a) of the Securities Exchange Act of 1934.

Filing Stats: 4,668 words · 19 min read · ~16 pages · Grade level 13.6 · Accepted 2024-12-30 16:15:22

Key Financial Figures

Filing Documents

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 36 Compensation Discussion and Analysis 36 Business Highlights 36 2024 Say-on-Pay Advisory Vote on Executive Compensation 37 Philosophy of Our Executive Compensation Programs 37 Program Overview 38 Pay for Performance 38 Key Changes for Fiscal Year 2025 Compensation and Governance Programs 40

Executive Compensation Practices Highlights

Executive Compensation Practices Highlights 41 How We Make Compensation Decisions 41 Fiscal Year 2024 Compensation Program and Pay Decisions 43 Fiscal Year 2024 Payouts 45

Executive Compensation Governance Policies

Executive Compensation Governance Policies 48 Compensation Committee Report 51 Summary Compensation Table 52 Grants of Plan-Based Awards 54 Outstanding Equity Awards at Fiscal Year End 56 Option Exercises and Stock Vested 58 Nonqualified Deferred Compensation 59 Potential Payments upon Termination, Change in Control, or upon Death or Disability 60 Potential Payments upon Termination of Employment in Connection with a Change in Control 63 Potential Payments upon a Corporate Transaction, and Equity Awards are Assumed, Continued, or Substituted 63 Potential Payments upon a Corporate Transaction, and Equity Awards are Not Assumed, Continued, or Substituted 63 Potential Payments upon Death or Disability 64 Compensation of Directors 64 Compensation Committee Interlocks and Insider Participation 66 Compensation Risk Management 67 CEO Pay Ratio 67 Pay Versus Performance 68 COMPANY POLICIES AND PRACTICES RELATED TO THE GRANT OF CERTAIN EQUITY AWARDS CLOSE IN TIME TO THE RELEASE OF MATERIAL NONPUBLIC INFORMATION 71 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS 71 Review, Approval or Ratification of Related Person Transactions 71 NOTE ABOUT FORWARD-LOOKING STATEMENTS 72 INFORMATION REFERENCED IN THIS PROXY STATEMENT 72 Appendix A A-1 Appendix B B-1 ii TABLE OF CONTENTS PROXY SUMMARY This summary highlights information contained elsewhere in this Proxy Statement but does not contain all of the information you should consider before voting. Please read the entire Proxy Statement carefully. Varex Imaging Corporation (" we ," " us ," " Varex ," or the " Company ") is a leading innovator, designer and manufacturer of X-ray imaging components, including X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems. Annual Meeting of Stockholders Meeting Agenda Date: Thursday, February 13, 2025 Election of seven dir

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing